Answers are grounded in this paper and cite their sources.
Brief Summary: An international panel of experts produced this consensus statement after critical review of the existing evidence on the safety of GH replacement in cancer and intracranial tumour survivors and in patients with increased cancer risk.
No takes yet. Share an insight, caveat, or question.
MCS et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: